Treatment of diabetes with copper bunding compounds
2 Assignments
0 Petitions
Accused Products
Abstract
Novel methods of treating a patient for diseases, disorders, and conditions including diabetes mellitus, comprising administering, for example, copper binding compounds.
52 Citations
110 Claims
-
1-50. -50. (canceled)
- 51. A method of treating a human suffering from one or more conditions associated with long-term complications of diabetes, which comprises administering a composition comprising a triene that binds copper in an amount ranging from about 9 mg/kg to about 200 mg/kg per day.
- 55. A method of preventing or ameliorating tissue damage in humans associated with diabetes mellitus which comprises prophylactic administration to a human an amount of a triene that binds copper in an amount ranging from about 9 mg/kg to about 200 mg/kg per day.
- 62. A method for treating or preventing macrovascular complications in a human with diabetes mellitus comprising administering to said human a triene that binds copper in an amount ranging from about 9 mg/kg to about 200 mg/kg per day.
- 67. A method for treating or preventing microvascular complications in a human with diabetes mellitus comprising administering to said human a triene that binds copper in an amount ranging from about 9 mg/kg to about 200 mg/kg per day.
- 72. A method for treating or preventing cardiovascular complications in a human with diabetes mellitus comprising orally administering to said human a triene that binds copper in an amount ranging from about 9 mg/kg to about 200 mg/kg per day.
- 78. A method for treating or preventing cardiomyopathy in a human with diabetes mellitus comprising administering to said human a triene that binds copper in an amount ranging from about 9 mg/kg to about 200 mg/kg per day.
- 83. A method for treating or preventing visual complications in a human with diabetes mellitus comprising administering to said human a triene that binds copper in an amount ranging from about 9 mg/kg to about 200 mg/kg per day.
- 89. A method for treating or preventing renal complications in a human with diabetes mellitus comprising administering to said human a triene that binds copper in an amount ranging from about 9 mg/kg to about 200 mg/kg per day.
-
96. A method for treating or preventing neuropathy in a human with diabetes mellitus comprising administering to said human a triene that binds copper in an amount ranging from about 9 mg/kg to about 200 mg/kg per day.
- 100. A method for improving wound healing in a human with diabetes mellitus comprising orally administering to said human a triene that binds copper in an amount ranging from about 9 mg/kg to about 200 mg/kg per day.
- 106. A method for improving weight gain or weight maintenance in a human with diabetes mellitus comprising administering to said human a triene that binds copper in an amount ranging from about 9 mg/kg to about 200 mg/kg per day.
Specification